TrialBlood2011

Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial.

Andrzej J Jakubowiak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.